Global Payments Inc. Stock Advances 4.8%, Outperforms Peers
Dow Jones2026/10/05 20:34This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Global Payments Inc. rose 4.8% to $82.18 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.7% to 7,773.95 and the Dow Jones Industrial Average rising 0.2% to 51,267.90. The stock's rise snapped a five-day losing streak. Global Payments Inc. closed 14.3% below its 52-week high of $95.88, which the company achieved on August 24th. The stock outperformed some of its peers, as PayPal Holdings Inc. rose 3.0% to $54.41, Fidelity National Information Services Inc. rose 3.5% to $33.58, and Fiserv Inc. rose 4.01% to $46.14. Trading volume totaled 2.4 million, compared to the 50-day average of 2.8 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 05, 2026 16:34 ET (20:34 GMT)
This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Global Payments Inc. rose 4.8% to $82.18 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.7% to 7,773.95 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.
The stock's rise snapped a five-day losing streak.
Global Payments Inc. closed 14.3% below its 52-week high of $95.88, which the company achieved on August 24th.
The stock outperformed some of its peers, as PayPal Holdings Inc. rose 3.0% to $54.41, Fidelity National Information Services Inc. rose 3.5% to $33.58, and Fiserv Inc. rose 4.01% to $46.14.
Trading volume totaled 2.4 million, compared to the 50-day average of 2.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 05, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
